Linjie Luo
- Co-authors
- Huaqin PanGuqin ZhangFang FangChang HuZhiyong PengJianguo LiYongfeng ChenKhandan Keyomarsi
- Topics
- Advanced Breast Cancer Therapies (7 papers)COVID-19 Clinical Research Studies (6 papers)Long-Term Effects of COVID-19 (6 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
Linjie Luo
23 papers receiving 688 citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Infectious Diseases 446
- Neurology 239
- Oncology 206
- Epidemiology 107
- Molecular Biology 79
Countries citing papers authored by Linjie Luo
This map shows the geographic impact of Linjie Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linjie Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linjie Luo more than expected).
Fields of papers citing papers by Linjie Luo
This network shows the impact of papers produced by Linjie Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linjie Luo. The network helps show where Linjie Luo may publish in the future.
Co-authorship network of co-authors of Linjie Luo
This figure shows the co-authorship network connecting the top 25 collaborators of Linjie Luo. A scholar is included among the top collaborators of Linjie Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linjie Luo. Linjie Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 14 | |
| 10 | 4 | |
| 11 | 10 | |
| 12 | 5 | |
| 13 | 9 | |
| 14 | 50 | |
| 15 | 15 | |
| 16 | Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, Chinabreakdown → | 507 |
| 17 | 12 | |
| 18 | 11 | |
| 19 | 30 | |
| 20 | 1 |
About Linjie Luo
Linjie Luo is a scholar working on Oncology, Neurology and Infectious Diseases, having authored 25 papers that have together received 703 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (7 papers), COVID-19 Clinical Research Studies (6 papers) and Long-Term Effects of COVID-19 (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (49 citations), Infectious Diseases (446 citations) and Neurology (239 citations). Linjie Luo has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Huaqin Pan, Guqin Zhang, Fang Fang, Chang Hu, Zhiyong Peng, Jianguo Li, Yongfeng Chen, Khandan Keyomarsi, Robin Fuchs‐Young and Isabel Lambertz. Their work appears in journals such as Gastroenterology, Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.